Cargando…

Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1

In cervical cancer (CC), cisplatin resistance greatly restricts the application in clinical. Here, we report that engineered exosomes-mediated transfer of hsa-miR-320a overcomes chemoresistance in cervical cancer cells via targeting Myeloid Cell Leukemia Sequence 1 (MCL1). In DDP resistant CC tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jinling, Wang, Yuanhe, Zhang, Lizhu, Chen, Qin, Zhu, Xiaojun, Jiang, Peiyue, Jiang, Nan, Zhao, Wei, Li, Baohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013939/ https://www.ncbi.nlm.nih.gov/pubmed/35444548 http://dx.doi.org/10.3389/fphar.2022.883445

Ejemplares similares

Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes
por: Zhu, Xiaojun, et al.
Publicado: (2022)

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
por: Al-Odat, Omar S., et al.
Publicado: (2021)

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
por: Fu, Dechen, et al.
Publicado: (2022)

Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
Publicado: (2021)

DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
por: Zhang, Jinyu, et al.
Publicado: (2020)

Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer
por: Gu, Xiaobin, et al.
Publicado: (2021)

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
por: Zhang, Ao, et al.
Publicado: (2023)

Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer
por: Li, Xinyuan, et al.
Publicado: (2022)

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p
por: Yang, Dan, et al.
Publicado: (2023)

The Fhit protein: an opportunity to overcome chemoresistance
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

The role of metabolic reprogramming in pancreatic cancer chemoresistance
por: Liu, Chang, et al.
Publicado: (2023)

Overcoming MCL-1-driven adaptive resistance to targeted therapies
por: Wood, Kris C.
Publicado: (2020)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
por: Li, Longxia, et al.
Publicado: (2022)

CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML
por: Zhong, An-Ni, et al.
Publicado: (2021)

Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320
por: Gao, Xiaotong, et al.
Publicado: (2019)

Recent advances of exosomes in age-related macular degeneration
por: Gu, Feng, et al.
Publicado: (2023)

Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells
por: Liao, Mingmei, et al.
Publicado: (2011)

Circular RNA hsa_circ_0003574 as a biomarker for prediction and diagnosis of ischemic stroke caused by intracranial atherosclerotic stenosis
por: Li, Lingfei, et al.
Publicado: (2022)

Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
por: Fan, Jia, et al.
Publicado: (2018)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

Overcoming Chemoresistance via Extracellular Vesicle Inhibition
por: Hayatudin, Raeesah, et al.
Publicado: (2021)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990
por: Chen, Bin, et al.
Publicado: (2022)

3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 Inhibition
por: Kawiak, Anna, et al.
Publicado: (2019)

Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway
por: Xu, Xueliang, et al.
Publicado: (2020)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

LncRNA NONHSAT114552 Sponges miR-320d to Promote Proliferation and Invasion of Chordoma Through Upregulating NRP1
por: Zhang, Kai, et al.
Publicado: (2021)

CD8(+) T cell–Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance
por: Lao, Liyan, et al.
Publicado: (2023)

The Emerging Role of Exosomes in Cancer Chemoresistance
por: Li, Jing, et al.
Publicado: (2021)

Exosomes and their roles in the chemoresistance of pancreatic cancer
por: Pan, Yubin, et al.
Publicado: (2022)

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990
por: Frontiers Editorial Office
Publicado: (2023)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021)

Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers
por: Palve, Vinayak, et al.
Publicado: (2014)

Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options
por: Wu, Xiaowei, et al.
Publicado: (2020)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4hpbmmv6lmmlitfe8vc9ousji7